Tag: Stem Cells

TGA Strengthened Regulation of Stem Cell Treatments in Australia

stem-cells
The Therapeutic Goods Administration (TGA) has strengthened the regulation of stem cell treatments in Australia. The new regulations maintain consumer access to established stem cell treatments while ...

Apexan Pharmaceuticals Got $2.3 mln from NHLBI for Study

Apexan Pharmaceuticals has announced that The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a $2.3 million grant to Dr. Reuben Kapur and Dr. M...

Century Therapeutics Launched Allogeneic Cell Therapy Platform

Bayer
Century Therapeutics, a Versant Ventures-created company developing allogeneic or off-the-shelf immune cell therapies for cancer, emerged from stealth mode today with USD 250 million in financing comm...

FDA’s Statement on Stem Cell Clinic Permanent Injunction

fda office
U.S. District Judge Ursula Ungaro of the Southern District of Florida issued an order that stops US Stem Cell Clinic LLC, of Weston, Florida, and US Stem Cell Inc., of Sunrise, Florida, and their Chie...

InGeneron Announced the Extension of Series D Financing

stem-cell
InGeneron, Inc., a clinical stage regenerative medicine and cell therapy company, announced the extension of its Series D financing by up to $23 million, totaling up to $43 million to be invested in t...

Israeli Researches to Turn Skin Cells into Embryo Stem Cells

An Israeli study said on Wednesday that Israeli researchers have found a way to turn skin cells into embryo stem cells, which could lead to the creation of a complete embryo from skin cells. In the...

Russia to Grow in Stem Cell Field

The widespread global outreach potential of stem cell therapies is becoming apparent, especially given the recent news of a second person going into long-term remission (some saying “cured”) of HIV af...

Second Patient in Remission from HIV after Stem Cell Transplant

An HIV positive man in London has become the second person ever to be declared in remission from the virus. The case is a proof of the concept that scientists will one day be able to end AIDS, his ...

Sechenov and Karolinska’ Research in Stem Cell Field

The international research team found a stem-cell niche in the growing bones that allows to produce new cells. “The new mechanism of bone growth is based on a completely new principle of the stem-c...

End of First Patient’s Treatment in AIVITA’s Ovarian Cancer Trial

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that its first patient has completed treatment in its multi-center Phase 2 ROOT OF CANCER ovaria...

Cellect Scaled Up Manufacturing of FasL

stem-cell
Cellect Biotechnology, a developer of a novel stem cell production technology, today announced it has concluded the scale-up development and manufacturing of clinical grade FasL in collaboration with ...

Japanese Company to Develop Type 1 Diabetes Cell Therapy

Japan’s Daiichi Sankyo has joined an open innovation research initiative that will try to develop a therapy for type 1 diabetes based on insulin-producing cells. The drugmaker has teamed up with To...

Bellicum Pharmaceuticals unveiled its first CAR-T candidate

car-t
Bellicum Pharmaceuticals, a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, reported safety and promising activity of BPX-601.

Allele Biotech produced six iPSCs lines

San Diego-based company produces induced pluripotent stem cells with cGMP control from donors. After three years of cleanroom construction and two years of quality system establishment, Allele Biot...

Scientists from Sechenov University published a new study in stem cell therapy

stem-cells
Research team from Sechenov University published a review of treatment strategies involving mesenchymal stem cells that are used to combat the consequences of ischemic heart disease.

Axol Bioscience unveiled a new line of human iPSC-derived microglia

stem cells
Axol Bioscience (UK), the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia.